Revolutionising Cancer Care

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) hosted at the University of Cambridge, with funding from The Mark Foundation for Cancer Research and the Cancer Research UK Cambridge Centre, aims to revolutionise cancer care by re-inventing the treatment pathway for patients.

Re-inventing the Patient Pathway

Research Areas

Breast Cancer

Read more Arrow

Ovarian Cancer

Read more Arrow

Pancreatic Cancer

Read more Arrow

Renal Cancer

Read more Arrow

Latest Updates

You can find a full list of media coverage about MFICM on the News page

CRUK Early Detection and Diagnosis Primer Awards Success!

CRUK Early Detection and Diagnosis Primer Awards Success!

Congratulations to Zeyu Gao on being awarded funding.

Read More Arrow
Cambridge MedAI Seminar: “Who Wants to Hack You? Threat Modelling for Medical AI”

Cambridge MedAI Seminar: “Who Wants to Hack You? Threat Modelling for Medical AI”

Tuesday 29 September 2026, 12:00 -13:00 at the Jeffrey Cheah Biomedical Centre, Main Lecture Theatre.

Read More Arrow
Congratulations to Gabriel Funingana

Congratulations to Gabriel Funingana

Who has been invited to co-lead the Pan-Cancer and Molecular Oncology Community at Genomics England.

Read More Arrow
New funding received from the Ovarian Cancer Alliance

New funding received from the Ovarian Cancer Alliance

To use AI to personalise ovarian cancer treatment

Read More Arrow

Key statistics

 
 
 
 
 
 
Statistics map
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect